Fair Isaac Corporation rallied 7.6% on the week to close at $1,043.57, lifted by a Q2 earnings beat that pushed the stock up nearly 3% the day after results. What makes the setup interesting is that short sellers used the rally to add — not exit — positioning.
Short interest has climbed to 6.3% of the free float, up from roughly 5.4% in early April. That is a meaningful 7-week build. The April 23 jump was particularly sharp: shorts added almost 100,000 shares in a single session, taking the position from 5.9% to 6.3%. Cost to borrow remains cheap at 0.44% APR, edging up about 10% on the week but still well within normal range. Availability is loose — plenty of shares remain in the lending pool relative to what is already borrowed — so there is no friction preventing further short accumulation. The short score of 43.6 is mid-range, consistent with measured rather than extreme conviction. What it adds up to: shorts are rebuilding after the earnings-driven rally, not capitulating into it.
Options traders turned noticeably more cautious this week. The put/call ratio jumped to 0.82 on April 29, almost three standard deviations above its 20-day average of 0.63. That is the most defensive hedging posture seen on FICO in recent weeks. The PCR has climbed sharply from below 0.60 in mid-April, suggesting fresh demand for downside protection even as the stock reclaimed the $1,000 handle. It is a notable divergence: the stock is moving higher on earnings relief, but options market participants are buying protection against a reversal.
The Street has been busy trimming targets. Wells Fargo cut its price objective by a substantial $650 to $1,650 last week while holding its Overweight rating. Needham also lowered from $1,975 to $1,650 the same day, sticking with Buy. Across the board — Goldman, Barclays, JP Morgan, UBS, Baird — the direction of travel has been downward on targets over the past six weeks. The consensus mean sits at $1,570, implying about 50% upside from current levels. That gap is real and reflects how far the stock has fallen from highs north of $2,000 earlier this year. Mizuho initiated in mid-April with an Outperform and $1,416 target. Bulls point to the Scores segment growing at nearly 30% year-over-year, with pricing power in mortgage and auto driving the beat. Bears flag a quarter-on-quarter revenue dip and softness in non-platform ARR as signs the software business is not pulling its weight. At a trailing P/E of 22x, the stock is not cheap on earnings, but the EV/EBITDA of 16.7x is more reasonable given the franchise quality.
On ownership, Capital Research added nearly 395,000 shares in Q1 — the largest single institutional move among top holders. BlackRock added roughly 48,000 shares in the same period. Principal Global added 54,000. The passive and active money is broadly stable-to-growing. Insider activity is quiet, with the most recent open-market transactions being director sales in February at prices well above current levels. The CFO sold a small tranche in January at $1,665; those trades look routine rather than directional.
The next earnings event is July 31. Between now and then, the tension worth tracking is whether shorts continue to rebuild on any further recovery toward $1,100–$1,200, and whether the options market's elevated put demand reflects genuine macro concern or simply post-earnings position management unwinding on the next leg higher.
See the live data behind this article on ORTEX.
Open FICO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
